
Thursday, September 03, 2020 7:43:21 PM
If Thero is serious about GIA in EU I would not be surprised to see this venture back to a buck a share in the near future. It will take time to generate EU revenue (IMHO).
Our best scenario is Thero gets canned tomorrow and someone new comes in to get a deal done (again IMHO)

Liked By
Spread the love. Be the first to like this post!
Recent AMRN News
- ADRs End Lower; Amarin, ArcelorMittal Trade Actively • Dow Jones News • 01/27/2023 10:48:00 PM
- Proxy Soliciting Materials (revised) (prrn14a) • Edgar (US Regulatory) • 01/27/2023 09:36:24 PM
- Proxy Soliciting Materials (revised) (prer14a) • Edgar (US Regulatory) • 01/27/2023 09:09:58 PM
- Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand • GlobeNewswire Inc. • 01/27/2023 01:45:00 PM
- Proxy Soliciting Materials (revised) (prer14a) • Edgar (US Regulatory) • 01/27/2023 01:03:05 PM
- Amarin to Present at SVB Securities Global Biopharma Conference • GlobeNewswire Inc. • 01/27/2023 01:00:00 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 01/23/2023 10:16:57 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 01/19/2023 09:07:08 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 01/19/2023 09:01:47 PM
- Proxy Statement - Contested Solicitations (preliminary) (prec14a) • Edgar (US Regulatory) • 01/19/2023 01:43:40 PM
- Amarin Responds to Inaccurate and Misleading Statement by Sarissa • GlobeNewswire Inc. • 01/19/2023 12:00:00 PM
- Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) • Edgar (US Regulatory) • 01/18/2023 10:25:11 PM
- Sarissa Capital Calls Out Amarin’s Sham Board Refreshment • Business Wire • 01/18/2023 12:30:00 PM
- Proxy Statement - Contested Solicitations (preliminary) (prec14a) • Edgar (US Regulatory) • 01/17/2023 01:08:33 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 01/12/2023 02:29:40 PM
- Amarin Comments on Sarissa’s Notice to Call a Special Meeting of Amarin Shareholders • GlobeNewswire Inc. • 01/11/2023 09:33:31 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 01/11/2023 11:02:38 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/10/2023 10:27:26 PM
- Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) • Edgar (US Regulatory) • 01/10/2023 09:45:20 PM
- Sarissa Capital Submits Notice to Call a Special Meeting of Amarin Shareholders to Add Directors and Remove Chairman Per Wold-Olsen • Business Wire • 01/10/2023 06:34:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/10/2023 12:18:34 PM
- Amarin Provides Preliminary Fourth Quarter and Full Year 2022 Revenue and Cash Position and Priorities for 2023 • GlobeNewswire Inc. • 01/10/2023 12:15:00 PM
- Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP • GlobeNewswire Inc. • 01/10/2023 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/03/2023 12:02:25 PM
- Amarin to Present at the 41st Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/14/2022 12:00:00 PM
FEATURED 1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition • Jan 27, 2023 11:59 AM
IQST - iQSTEL Reminds Shareholders To Get Their Votes In Before Annual Meeting Next Week On January 31, 2023 • IQST • Jan 26, 2023 9:53 AM
Nextech AR's AI-Powered CAD to Poly Toggle3D Launches Major Technology Advancements • ARWYF • Jan 26, 2023 8:46 AM
UCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023 • UCASU • Jan 26, 2023 7:21 AM
Kaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market • KAYS • Jan 25, 2023 10:53 AM
B2 Digital's B2 SPORTS NETWORK (B2SN) Expands Distribution to Europe, Russia, and Asia with StayLIVE Agreement • BTDG • Jan 25, 2023 10:00 AM